Mobia Medical (NASDAQ:MOBI) was initiated with a ‘Buy' rating and a $16 price target by Bank of America, which cited the company's growth potential in stroke recovery treatment and a large addressable market for its Vivistim system. Mobia's Vivistim therapy combines rehabilitation exercises with a vagus nerve stimulation (VNS) device designed to help chronic stroke survivors improve upper-limb function.
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
Keith Schoenfeld Mowery & Schoenfeld Wealth Management, LLC | 3,250 | $47,222.5 | $40,040 | -$7,182.5 | -15.21% |
| Household Durables Industry | Consumer Discretionary Sector | Richard Foust CEO | NASDAQ (NGS) Exchange | 60705V103 CUSIP |
| US Country | 167 Employees | - Last Dividend | - Last Split | - IPO Date |
Mobia Medical, Inc. is a commercial-stage medical device company that specializes in developing innovative solutions aimed at aiding stroke recovery for survivors who experience motor impairments. Since its founding on March 5, 2007, by Lawrence James Cauller, Navzer Engineer, Thomas Jordan Curnes II, and William Michael Rosellini, the company has focused on leveraging advanced technologies to improve the rehabilitation process. Based in Austin, TX, Mobia Medical is committed to enhancing the lives of those affected by strokes by providing effective recovery tools and devices.
Mobia Medical develops sophisticated devices designed to assist individuals in their rehabilitation journey after a stroke. These devices are engineered to facilitate motor skill recovery, helping users regain independence and improve their quality of life.
The company offers targeted solutions specifically aimed at addressing various forms of motor impairments caused by strokes. These solutions incorporate advanced technologies to tailor rehabilitation exercises according to individual patient needs, enhancing effectiveness and promoting faster recovery.
Mobia Medical recognizes the importance of continuous support during the recovery process. As such, the company provides telehealth services, allowing patients to receive expert guidance and monitoring from healthcare professionals remotely, ensuring adherence to rehabilitation plans and maximizing recovery outcomes.
To empower stroke survivors and their families, Mobia Medical offers educational programs that inform them about stroke recovery processes, available treatment options, and effective exercises to boost rehabilitation efforts. These programs are designed to enhance understanding and motivation among patients and caregivers.
Continuous innovation is at the core of Mobia Medical’s operations. The company engages in extensive research and development to explore new technologies and methodologies that can improve rehabilitation for stroke survivors. This commitment to R&D positions the company as a leader in the medical device industry focused on motor recovery.